Chordoma Foundation


General Characteristics

Age: 83 years
Gender: Male
Disease Origin: Sacral
Disease Status: Primary
Source: Silke Bruderlein, Peter Moller
University of Ulm


Molecular Features

Cell morphology: Physaliferous
T expression: Positive; 12.9x that of U-CH2
T localization: Nuclear
CD24 expression: Positive; 10.2x that of U-CH2
HLA Type:
Chromosomal abnormalities: Uncharacterized
Validation results: Validation Report


Growth Conditions

Growth medium: IMDM: RPMI-1640 (4:1) +10% FBS
Freeze medium: 70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO
Culture conditions: Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing instructions: Cell Culture Procedures



Characterized By:

  • Cancer Res. 2015 Sep 15;75(18):3823-31. doi: 10.1158/0008-5472.CAN-14-3270. Epub 2015 Jul16.   Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting byPharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.  von Witzleben A1

Pin It on Pinterest

Share This
Comodo SSL